Skip to main content

and
  1. Article

    Open Access

    The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours

    The novel opioid receptor antagonist, GSK1421498, has been shown to attenuate reward-driven compulsive behaviours, such as stimulant drug seeking or binge eating, in animals and humans. Here, we report new dat...

    Eamonn Kelly, Stuart J. Mundell, Anna Sava, Adelheid L. Roth in Psychopharmacology (2015)